Republished from The Children's Prize Foundation Newsletter
Oncolinx, in conjunction with the National Cancer Institute is developing the next generation of targeted cancer therapies: antibody-drug conjugates (ADCs). Oncolinx ADCs carry a patented, immune-activating drug payload called the Azonafide directly, and exclusively, to cancer cells, and not healthy cells, thereby avoiding many of the adverse side-effects of chemotherapy.
WASHINGTON (AP) — Students from across the country submitted videos for the Spellebrity Video Contest, and our judges chose their top ten. Now it's your turn! Vote for your favorite video by clicking "Vote" above and help send five student teams to Washington, D.C., to premiere their videos at Bee Week.
The competition is an opportunity for individuals or teams of up to four people to...
Each year, the 43North business competition awards $5 million in cash prizes and services to some of the best and brightest entrepreneurs and startups from around the globe. Awards include a one $1 million grand prize, six $500,000 prizes and four $250,000 prizes.
43North is part of New York Governor Andrew Cuomo’s Buffalo Billion initiative, which is driving new economic opportunities...
The Collegiate Inventors Competition® is a unique competition that can take your invention to the next level through networking, marketing exposure, mentorship and more!
Since 1990, with the help of our sponsors, we have awarded more than $1 million to students nationwide.
Meet the students who will compete in Washington D.C., and find out why their inventions stand out among this year’s most...
In partnership with the Red Cross, The Paradigm Challenge is an annual competition that inspires youth innovation to address important social issues. The first annual Challenge sought to generate new ideas to prevent injuries and fatalities from home fires—America’s #1 disaster threat.